The United States has twice the postpartum hemorrhage mortality rate of other developed countries, which is why it’s essential to create and maintain safety protocols during obstetric emergencies, according to Abigail Wooldridge, assistant professor of Industrial and Enterprise Systems Engineering at The University of Illinois.
In the United States in 2018, there were 17 maternal deaths for every 100,000 births, which is double the rate in other high-income countries such as Canada and France, which averaged 8 deaths per 100,000 births, according to a report by the National Center for Health Statistics.
A recent study published in the journal healthcare on safety culture within delivery rooms suggests there is room for improvement in terms of staffing, communication and organizational management.
The study was led by Abigail Wooldridge, assistant professor of Industrial and Enterprise Systems Engineering at The University of Illinois. Wooldridge recently sat down with Managed Healthcare Executive to discuss the findings of her team.
“If you can't get the bleeding under control, someone will die,” Wooldridge said in an interview with Managed Healthcare Executive. “One of the last resort treatments for postpartum hemorrhage would be a hysterectomy. Our work is arguing that we need to find systems and processes and structures that can help support clinicians in anticipating risk, detecting the hemorrhage and then responding in an appropriate, timely way.”
Abigail Wooldridge
Postpartum hemorrhage is defined as heavy bleeding after childbirth, specifically more than 500 mL of estimated blood loss in a vaginal delivery or more than 1000 mL of estimated blood loss during Cesarean delivery. It requires immediate medical attention.
U.S. Has Highest Maternal Death Rate Among High-Income Countries, Experts Cite Funding Gaps
June 6th 2025The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of federal funding of pregnancy research, according to a review published in JAMA Health Forum.
Read More
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
Menopause Under Researched in Transgender and Gender Diverse Individuals, Study Shows
April 28th 2025There is a lack of agreement on the clinical, psychological and social relevance of menopause between the transgender and gender diverse communities and medical professionals, according to the results of a study published this month in Menopause.
Read More